Robert Meguid
Concepts (411)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 68 | 2026 | 2977 | 11.790 |
Why?
| | Surgical Procedures, Operative | 15 | 2025 | 271 | 6.700 |
Why?
| | Esophagectomy | 18 | 2024 | 135 | 6.240 |
Why?
| | Esophageal Neoplasms | 21 | 2025 | 348 | 5.820 |
Why?
| | Pneumonectomy | 12 | 2025 | 167 | 4.830 |
Why?
| | Surgeons | 11 | 2026 | 340 | 3.930 |
Why?
| | Thoracic Surgery | 9 | 2026 | 143 | 3.600 |
Why?
| | Preoperative Care | 9 | 2026 | 380 | 3.110 |
Why?
| | Risk Assessment | 31 | 2026 | 3752 | 2.970 |
Why?
| | Quality Improvement | 24 | 2025 | 1296 | 2.960 |
Why?
| | Thoracic Surgical Procedures | 7 | 2025 | 94 | 2.830 |
Why?
| | Surgical Wound Infection | 8 | 2025 | 329 | 2.740 |
Why?
| | Lung Neoplasms | 15 | 2026 | 2668 | 2.450 |
Why?
| | Robotic Surgical Procedures | 8 | 2025 | 185 | 2.430 |
Why?
| | Retrospective Studies | 68 | 2026 | 17330 | 2.330 |
Why?
| | Length of Stay | 13 | 2025 | 1350 | 2.290 |
Why?
| | Electronic Health Records | 9 | 2025 | 1202 | 2.240 |
Why?
| | Inpatients | 5 | 2023 | 553 | 2.220 |
Why?
| | Databases, Factual | 22 | 2025 | 1491 | 2.070 |
Why?
| | Laparoscopy | 6 | 2024 | 481 | 2.030 |
Why?
| | Ischemic Preconditioning | 4 | 2024 | 47 | 1.960 |
Why?
| | Urinary Tract Infections | 5 | 2025 | 210 | 1.930 |
Why?
| | Time-to-Treatment | 5 | 2025 | 251 | 1.850 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 8 | 2025 | 1192 | 1.790 |
Why?
| | Aged | 57 | 2026 | 26217 | 1.780 |
Why?
| | Risk Factors | 35 | 2026 | 10919 | 1.720 |
Why?
| | Middle Aged | 67 | 2026 | 36309 | 1.690 |
Why?
| | Anastomosis, Surgical | 4 | 2024 | 163 | 1.620 |
Why?
| | Hypothermia | 2 | 2025 | 53 | 1.620 |
Why?
| | Humans | 141 | 2026 | 145783 | 1.560 |
Why?
| | Specialties, Surgical | 3 | 2023 | 82 | 1.510 |
Why?
| | Patient Readmission | 8 | 2025 | 773 | 1.500 |
Why?
| | Minimally Invasive Surgical Procedures | 6 | 2024 | 189 | 1.320 |
Why?
| | Sepsis | 5 | 2025 | 664 | 1.290 |
Why?
| | Hospitals | 8 | 2025 | 733 | 1.260 |
Why?
| | United States | 39 | 2026 | 16126 | 1.260 |
Why?
| | Hospital Mortality | 11 | 2022 | 1038 | 1.260 |
Why?
| | Male | 76 | 2026 | 73011 | 1.240 |
Why?
| | Cardiac Surgical Procedures | 3 | 2025 | 611 | 1.210 |
Why?
| | Models, Statistical | 5 | 2025 | 672 | 1.200 |
Why?
| | Female | 75 | 2026 | 79045 | 1.190 |
Why?
| | Emergency Treatment | 2 | 2021 | 123 | 1.190 |
Why?
| | Informed Consent | 2 | 2020 | 199 | 1.100 |
Why?
| | Machine Learning | 6 | 2025 | 587 | 1.090 |
Why?
| | Adenocarcinoma | 5 | 2024 | 926 | 1.020 |
Why?
| | Esophageal Stenosis | 2 | 2024 | 60 | 0.980 |
Why?
| | Adult | 45 | 2026 | 40881 | 0.940 |
Why?
| | Intensive Care Units | 2 | 2022 | 924 | 0.920 |
Why?
| | Guideline Adherence | 4 | 2024 | 587 | 0.900 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2023 | 79 | 0.890 |
Why?
| | Thoracic Surgery, Video-Assisted | 3 | 2026 | 56 | 0.850 |
Why?
| | Patient Discharge | 3 | 2020 | 995 | 0.840 |
Why?
| | Travel | 1 | 2025 | 136 | 0.820 |
Why?
| | Shock, Septic | 2 | 2023 | 227 | 0.800 |
Why?
| | Lung Transplantation | 7 | 2023 | 332 | 0.790 |
Why?
| | Metastasectomy | 1 | 2023 | 19 | 0.770 |
Why?
| | Hernia, Hiatal | 1 | 2023 | 39 | 0.770 |
Why?
| | Treatment Outcome | 21 | 2025 | 11794 | 0.760 |
Why?
| | Perioperative Care | 1 | 2025 | 231 | 0.760 |
Why?
| | Evidence-Based Practice | 2 | 2024 | 231 | 0.740 |
Why?
| | Logistic Models | 9 | 2023 | 2139 | 0.730 |
Why?
| | Seasons | 1 | 2025 | 538 | 0.710 |
Why?
| | General Surgery | 4 | 2021 | 206 | 0.700 |
Why?
| | Neoplasm Staging | 8 | 2025 | 1475 | 0.670 |
Why?
| | Critical Pathways | 1 | 2022 | 111 | 0.670 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 293 | 0.650 |
Why?
| | Thoracotomy | 2 | 2026 | 88 | 0.640 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 22 | 0.640 |
Why?
| | Internet | 1 | 2025 | 693 | 0.640 |
Why?
| | Patient Admission | 1 | 2022 | 220 | 0.630 |
Why?
| | Rectal Prolapse | 1 | 2020 | 24 | 0.610 |
Why?
| | Physicians, Women | 3 | 2026 | 90 | 0.600 |
Why?
| | Patient Satisfaction | 2 | 2022 | 712 | 0.590 |
Why?
| | Cohort Studies | 11 | 2023 | 6033 | 0.580 |
Why?
| | Anastomotic Leak | 4 | 2024 | 45 | 0.570 |
Why?
| | Prognosis | 9 | 2025 | 4330 | 0.560 |
Why?
| | Aftercare | 1 | 2020 | 222 | 0.560 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 328 | 0.560 |
Why?
| | Thoracoscopy | 2 | 2020 | 60 | 0.550 |
Why?
| | Hospitals, Teaching | 2 | 2009 | 121 | 0.540 |
Why?
| | Outpatients | 1 | 2022 | 447 | 0.540 |
Why?
| | Preoperative Period | 5 | 2025 | 149 | 0.540 |
Why?
| | Time Factors | 11 | 2026 | 7134 | 0.530 |
Why?
| | Patient Transfer | 2 | 2019 | 211 | 0.510 |
Why?
| | Morbidity | 4 | 2023 | 322 | 0.490 |
Why?
| | Survival Rate | 11 | 2025 | 2094 | 0.490 |
Why?
| | Stomach | 4 | 2024 | 111 | 0.490 |
Why?
| | Neoadjuvant Therapy | 4 | 2024 | 467 | 0.490 |
Why?
| | Propensity Score | 4 | 2026 | 377 | 0.480 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 928 | 0.470 |
Why?
| | Tissue and Organ Procurement | 4 | 2023 | 343 | 0.450 |
Why?
| | Postoperative Care | 2 | 2016 | 286 | 0.440 |
Why?
| | Data Collection | 1 | 2017 | 643 | 0.430 |
Why?
| | Trachea | 1 | 2016 | 258 | 0.420 |
Why?
| | Risk Adjustment | 2 | 2025 | 85 | 0.400 |
Why?
| | Aged, 80 and over | 10 | 2025 | 8347 | 0.390 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 327 | 0.390 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 249 | 0.380 |
Why?
| | Clinical Protocols | 2 | 2024 | 280 | 0.360 |
Why?
| | Quality of Life | 2 | 2024 | 3211 | 0.360 |
Why?
| | Emergencies | 2 | 2025 | 174 | 0.350 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2011 | 167 | 0.340 |
Why?
| | Societies, Medical | 3 | 2024 | 900 | 0.330 |
Why?
| | Prospective Studies | 6 | 2024 | 8078 | 0.320 |
Why?
| | Conversion to Open Surgery | 2 | 2020 | 22 | 0.310 |
Why?
| | Thoracic Neoplasms | 2 | 2020 | 39 | 0.310 |
Why?
| | Veterans | 1 | 2022 | 1642 | 0.300 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 498 | 0.300 |
Why?
| | Pandemics | 5 | 2025 | 1711 | 0.300 |
Why?
| | Reoperation | 3 | 2026 | 637 | 0.300 |
Why?
| | Pregnancy Complications | 1 | 2015 | 603 | 0.300 |
Why?
| | Aneurysm, Ruptured | 1 | 2009 | 38 | 0.290 |
Why?
| | Quality Assurance, Health Care | 3 | 2021 | 342 | 0.280 |
Why?
| | Incidence | 3 | 2025 | 2934 | 0.270 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 66 | 0.260 |
Why?
| | Triage | 2 | 2020 | 250 | 0.260 |
Why?
| | Disease-Free Survival | 3 | 2023 | 770 | 0.250 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 88 | 0.250 |
Why?
| | Pancreaticoduodenectomy | 1 | 2008 | 137 | 0.250 |
Why?
| | Follow-Up Studies | 6 | 2025 | 5428 | 0.240 |
Why?
| | Histoplasma | 1 | 2026 | 11 | 0.240 |
Why?
| | Chylothorax | 2 | 2017 | 20 | 0.240 |
Why?
| | Antibodies, Fungal | 1 | 2026 | 11 | 0.240 |
Why?
| | Hemothorax | 1 | 2026 | 19 | 0.240 |
Why?
| | Diaphragm | 2 | 2023 | 48 | 0.240 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2026 | 25 | 0.240 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2026 | 23 | 0.240 |
Why?
| | Coronary Artery Bypass | 2 | 2025 | 268 | 0.240 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3418 | 0.240 |
Why?
| | Career Choice | 2 | 2026 | 235 | 0.240 |
Why?
| | Pneumonia | 2 | 2023 | 636 | 0.230 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 258 | 0.230 |
Why?
| | Age Factors | 2 | 2025 | 3346 | 0.230 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 336 | 0.230 |
Why?
| | Chemoradiotherapy | 2 | 2024 | 239 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 391 | 0.210 |
Why?
| | Postoperative Hemorrhage | 2 | 2023 | 105 | 0.210 |
Why?
| | Pancreatectomy | 1 | 2008 | 289 | 0.210 |
Why?
| | Coronavirus Infections | 2 | 2020 | 384 | 0.210 |
Why?
| | Case-Control Studies | 5 | 2024 | 3634 | 0.210 |
Why?
| | Organizational Culture | 1 | 2026 | 162 | 0.210 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1582 | 0.210 |
Why?
| | Vulnerable Populations | 1 | 2025 | 176 | 0.210 |
Why?
| | Smoking | 2 | 2012 | 1477 | 0.200 |
Why?
| | Spouses | 1 | 2025 | 109 | 0.200 |
Why?
| | Workplace | 1 | 2026 | 272 | 0.200 |
Why?
| | Geriatric Assessment | 1 | 2025 | 240 | 0.200 |
Why?
| | Respiratory Paralysis | 1 | 2023 | 4 | 0.200 |
Why?
| | Comorbidity | 3 | 2022 | 1662 | 0.190 |
Why?
| | Feasibility Studies | 2 | 2019 | 1115 | 0.190 |
Why?
| | Mentors | 1 | 2025 | 217 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3916 | 0.190 |
Why?
| | Herniorrhaphy | 1 | 2023 | 76 | 0.190 |
Why?
| | Fluorouracil | 1 | 2023 | 231 | 0.180 |
Why?
| | Algorithms | 3 | 2019 | 1851 | 0.180 |
Why?
| | Colorectal Surgery | 1 | 2022 | 30 | 0.180 |
Why?
| | Advisory Committees | 1 | 2023 | 229 | 0.180 |
Why?
| | Periodicals as Topic | 1 | 2024 | 209 | 0.170 |
Why?
| | Qualitative Research | 3 | 2026 | 1683 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1327 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 1150 | 0.170 |
Why?
| | Social Determinants of Health | 1 | 2025 | 309 | 0.170 |
Why?
| | Databases as Topic | 1 | 2021 | 71 | 0.170 |
Why?
| | Heart Transplantation | 2 | 2023 | 680 | 0.160 |
Why?
| | Tissue Donors | 2 | 2023 | 420 | 0.160 |
Why?
| | Leadership | 1 | 2025 | 402 | 0.160 |
Why?
| | Focus Groups | 1 | 2023 | 572 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 289 | 0.160 |
Why?
| | Lung | 2 | 2024 | 4116 | 0.160 |
Why?
| | Family | 1 | 2025 | 685 | 0.160 |
Why?
| | Arthroplasty | 1 | 2020 | 59 | 0.150 |
Why?
| | Robotics | 1 | 2021 | 90 | 0.150 |
Why?
| | Intermediate Care Facilities | 1 | 2019 | 4 | 0.150 |
Why?
| | Fear | 1 | 2023 | 368 | 0.150 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 37 | 0.150 |
Why?
| | Benchmarking | 1 | 2021 | 191 | 0.150 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 203 | 0.150 |
Why?
| | Physical Fitness | 1 | 2020 | 207 | 0.150 |
Why?
| | Glutamine | 1 | 1999 | 109 | 0.140 |
Why?
| | Geography | 1 | 2019 | 187 | 0.140 |
Why?
| | Datasets as Topic | 1 | 2019 | 118 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2026 | 1329 | 0.140 |
Why?
| | Heat-Shock Proteins | 1 | 1999 | 139 | 0.140 |
Why?
| | Burnout, Professional | 1 | 2026 | 488 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 112 | 0.140 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 562 | 0.140 |
Why?
| | Hospitals, University | 1 | 2018 | 176 | 0.140 |
Why?
| | Overweight | 1 | 2023 | 614 | 0.130 |
Why?
| | Forecasting | 1 | 2019 | 390 | 0.130 |
Why?
| | Skilled Nursing Facilities | 1 | 2019 | 152 | 0.130 |
Why?
| | United States Department of Veterans Affairs | 1 | 2022 | 779 | 0.130 |
Why?
| | Altruism | 1 | 2017 | 27 | 0.130 |
Why?
| | Eating | 3 | 1995 | 387 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 560 | 0.130 |
Why?
| | Internship and Residency | 3 | 2021 | 1269 | 0.130 |
Why?
| | Thoracic Wall | 1 | 2017 | 21 | 0.130 |
Why?
| | Pylorus | 1 | 2017 | 17 | 0.130 |
Why?
| | Medical Oncology | 1 | 2020 | 340 | 0.120 |
Why?
| | Gastric Outlet Obstruction | 1 | 2017 | 12 | 0.120 |
Why?
| | Self Efficacy | 1 | 2020 | 413 | 0.120 |
Why?
| | Parenteral Nutrition | 2 | 1995 | 102 | 0.120 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 297 | 0.120 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 40 | 0.120 |
Why?
| | Medically Underserved Area | 1 | 2017 | 100 | 0.120 |
Why?
| | Abscess | 1 | 2017 | 77 | 0.120 |
Why?
| | Pleural Effusion | 1 | 2017 | 59 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 303 | 0.120 |
Why?
| | Pain Management | 1 | 2020 | 411 | 0.120 |
Why?
| | Postoperative Period | 4 | 2021 | 351 | 0.120 |
Why?
| | Neuromuscular Agents | 1 | 2017 | 46 | 0.120 |
Why?
| | Frailty | 1 | 2019 | 205 | 0.120 |
Why?
| | Clinical Competence | 3 | 2021 | 1247 | 0.120 |
Why?
| | Home Care Services | 1 | 2019 | 284 | 0.120 |
Why?
| | Botulinum Toxins, Type A | 1 | 2017 | 60 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1547 | 0.120 |
Why?
| | Chyle | 1 | 2015 | 4 | 0.110 |
Why?
| | Nutritional Support | 1 | 2015 | 39 | 0.110 |
Why?
| | Prevalence | 1 | 2022 | 2875 | 0.110 |
Why?
| | Health Status | 1 | 2021 | 835 | 0.110 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 292 | 0.110 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 66 | 0.110 |
Why?
| | Altitude | 1 | 2019 | 463 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2020 | 547 | 0.110 |
Why?
| | Osteomyelitis | 1 | 2017 | 146 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2019 | 578 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1969 | 0.110 |
Why?
| | Orthopedics | 1 | 2017 | 175 | 0.110 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2019 | 390 | 0.100 |
Why?
| | Biomedical Research | 1 | 2021 | 719 | 0.100 |
Why?
| | Hypotension | 1 | 2015 | 127 | 0.100 |
Why?
| | Hospitals, Veterans | 1 | 2015 | 258 | 0.100 |
Why?
| | Body Mass Index | 1 | 2023 | 2447 | 0.100 |
Why?
| | Proportional Hazards Models | 3 | 2018 | 1330 | 0.100 |
Why?
| | Radiosurgery | 1 | 2018 | 399 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 2000 | 0.100 |
Why?
| | Colorado | 3 | 2018 | 4556 | 0.100 |
Why?
| | Health Services Research | 1 | 2016 | 391 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1139 | 0.100 |
Why?
| | Proteins | 1 | 1999 | 1023 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2020 | 736 | 0.100 |
Why?
| | Hospitalization | 2 | 2021 | 2461 | 0.090 |
Why?
| | Esophagogastric Junction | 2 | 2024 | 55 | 0.090 |
Why?
| | Leiomyosarcoma | 1 | 2012 | 29 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2015 | 277 | 0.090 |
Why?
| | Decision Making | 1 | 2020 | 982 | 0.090 |
Why?
| | RNA, Messenger | 2 | 1999 | 2805 | 0.090 |
Why?
| | Heart Neoplasms | 1 | 2012 | 56 | 0.090 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 90 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1482 | 0.090 |
Why?
| | Energy Intake | 1 | 1995 | 512 | 0.090 |
Why?
| | Endoleak | 1 | 2011 | 17 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 2011 | 8 | 0.090 |
Why?
| | Intestinal Fistula | 1 | 2011 | 18 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6085 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 151 | 0.080 |
Why?
| | Transcription Factors | 1 | 1999 | 1736 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1372 | 0.080 |
Why?
| | Pulmonary Valve | 1 | 2012 | 102 | 0.080 |
Why?
| | Body Composition | 1 | 1995 | 693 | 0.080 |
Why?
| | Transplant Recipients | 2 | 2023 | 182 | 0.080 |
Why?
| | Adipose Tissue | 1 | 1995 | 645 | 0.080 |
Why?
| | Aortic Diseases | 1 | 2011 | 125 | 0.080 |
Why?
| | Hospitals, District | 1 | 2009 | 7 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 3118 | 0.070 |
Why?
| | Pancreas, Exocrine | 1 | 2008 | 7 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2968 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 528 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 920 | 0.070 |
Why?
| | Patient Selection | 3 | 2020 | 739 | 0.070 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 254 | 0.060 |
Why?
| | SEER Program | 1 | 2008 | 230 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 336 | 0.060 |
Why?
| | Precancerous Conditions | 1 | 2008 | 166 | 0.060 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 688 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 508 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1129 | 0.060 |
Why?
| | Hypertension | 1 | 2015 | 1276 | 0.060 |
Why?
| | Thoracostomy | 1 | 2026 | 27 | 0.060 |
Why?
| | Cause of Death | 1 | 2008 | 472 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 740 | 0.060 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 343 | 0.060 |
Why?
| | Sexism | 1 | 2026 | 68 | 0.050 |
Why?
| | Graft Survival | 2 | 2023 | 519 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 971 | 0.050 |
Why?
| | Job Satisfaction | 1 | 2026 | 238 | 0.050 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 107 | 0.050 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2025 | 154 | 0.050 |
Why?
| | Triglycerides | 2 | 2015 | 520 | 0.050 |
Why?
| | Odds Ratio | 2 | 2019 | 1083 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 7216 | 0.040 |
Why?
| | Interpersonal Relations | 1 | 2025 | 400 | 0.040 |
Why?
| | Colectomy | 1 | 2022 | 106 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 250 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 202 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 887 | 0.040 |
Why?
| | Learning Curve | 1 | 2021 | 71 | 0.040 |
Why?
| | Fatigue | 1 | 2023 | 366 | 0.040 |
Why?
| | Professional Practice Gaps | 1 | 2020 | 15 | 0.040 |
Why?
| | Registries | 2 | 2025 | 2410 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 22577 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 169 | 0.040 |
Why?
| | Child | 1 | 2020 | 22740 | 0.040 |
Why?
| | Glutaminase | 1 | 1999 | 11 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 1999 | 32 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 50 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2123 | 0.040 |
Why?
| | Hydrolysis | 1 | 1999 | 197 | 0.040 |
Why?
| | Walk Test | 1 | 2019 | 82 | 0.040 |
Why?
| | Serum Albumin | 1 | 2019 | 147 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2009 | 330 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 280 | 0.030 |
Why?
| | Sarcopenia | 1 | 2019 | 91 | 0.030 |
Why?
| | Cell Division | 1 | 1999 | 757 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1999 | 199 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 883 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 618 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 403 | 0.030 |
Why?
| | Alternative Splicing | 1 | 1999 | 248 | 0.030 |
Why?
| | Cell Line | 2 | 1999 | 2823 | 0.030 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2017 | 29 | 0.030 |
Why?
| | Education | 1 | 2017 | 105 | 0.030 |
Why?
| | Regression Analysis | 1 | 2019 | 1001 | 0.030 |
Why?
| | Clinical Audit | 1 | 2016 | 14 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 213 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 444 | 0.030 |
Why?
| | Gastric Emptying | 1 | 2017 | 36 | 0.030 |
Why?
| | Competency-Based Education | 1 | 2017 | 81 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 509 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 457 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 364 | 0.030 |
Why?
| | Cadaver | 1 | 2017 | 311 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 356 | 0.030 |
Why?
| | HIV Infections | 1 | 2012 | 3195 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 181 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2514 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 729 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 54 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3551 | 0.030 |
Why?
| | Dietary Fiber | 1 | 2015 | 59 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 173 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 102 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1898 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2444 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 145 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2015 | 135 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1995 | 154 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1271 | 0.030 |
Why?
| | Glycogen | 1 | 1993 | 55 | 0.030 |
Why?
| | Rats | 4 | 1995 | 5585 | 0.020 |
Why?
| | Poverty | 1 | 2017 | 529 | 0.020 |
Why?
| | Dietary Fats | 1 | 2015 | 308 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5925 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1454 | 0.020 |
Why?
| | Staphylococcus epidermidis | 1 | 1993 | 79 | 0.020 |
Why?
| | Mortality | 1 | 2015 | 381 | 0.020 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2012 | 149 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 67 | 0.020 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2012 | 78 | 0.020 |
Why?
| | Echocardiography, Transesophageal | 1 | 2012 | 132 | 0.020 |
Why?
| | Carbon Monoxide | 1 | 2012 | 82 | 0.020 |
Why?
| | Catheterization, Central Venous | 1 | 1993 | 123 | 0.020 |
Why?
| | Anesthesia, General | 1 | 1992 | 121 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1154 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 653 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1812 | 0.020 |
Why?
| | Peritonitis | 1 | 2011 | 83 | 0.020 |
Why?
| | Body Weight | 1 | 1995 | 972 | 0.020 |
Why?
| | Endoscopy, Digestive System | 1 | 2011 | 142 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2525 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 228 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 1993 | 393 | 0.020 |
Why?
| | Rats, Inbred F344 | 3 | 1993 | 268 | 0.020 |
Why?
| | California | 1 | 2009 | 473 | 0.020 |
Why?
| | Receptors, Notch | 1 | 2008 | 90 | 0.020 |
Why?
| | Safety | 1 | 2009 | 358 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 419 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 962 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2393 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2011 | 390 | 0.010 |
Why?
| | Liver | 1 | 1995 | 1899 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2008 | 644 | 0.010 |
Why?
| | Academic Medical Centers | 1 | 2008 | 554 | 0.010 |
Why?
| | Graft Rejection | 1 | 2008 | 521 | 0.010 |
Why?
| | Animals | 5 | 2008 | 38102 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1247 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2191 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14254 | 0.010 |
Why?
| | Brain | 1 | 1993 | 2969 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1999 | 203 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 273 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 387 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 362 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 295 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 538 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 267 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 778 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2171 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2131 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2883 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 5224 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 168 | 0.010 |
Why?
| | Chloral Hydrate | 1 | 1992 | 3 | 0.010 |
Why?
| | Periodicity | 1 | 1992 | 58 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 318 | 0.010 |
Why?
| | Organ Specificity | 1 | 1993 | 309 | 0.010 |
Why?
| | Food Preferences | 1 | 1992 | 126 | 0.010 |
Why?
| | Mice | 1 | 2008 | 18356 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1992 | 513 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1993 | 4568 | 0.000 |
Why?
|
|
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|